GE HealthCare Expands Electrophysiology Capabilities with AI-Powered Software Upgrades
GE HealthCare has launched AltiX AI.i editions for its three invasive cardiac software solutions—Mac-Lab, CardioLab, and ComboLab—following FDA clearance in December 2024. These AI-driven upgrades are designed to enhance cath lab workflows, streamline electrophysiology (EP) procedures, and improve the overall user experience.
The Mac-Lab AltiX AI.i edition builds upon existing cardiac catheterization capabilities by integrating an advanced algorithm for diastolic pressure ratio (dPR) measurement, alongside the diastolic hyperemia-free ratio (DFR). These innovations aid in more accurate assessment of coronary artery disease (CAD) severity, providing precise diagnostics for better treatment decisions.
With the electrophysiology market experiencing continuous growth, GE HealthCare's latest AI-powered advancements signal its commitment to innovation in cardiac care. These solutions aim to support complex cardiac procedures, making diagnosis and intervention more efficient for clinicians and patients alike.
18-03-2025